INTRODUCTION AND OBJECTIVES: Clinically, mid-urethral sling procedure has become a regular and popular treatment for stress urinary incontinence (SUI). However, it has limited improvement if intrinsic sphincter deficiency dominantly and/or co-existing serious urgency symptom. We applied a new neuro-modulative sling in an acute urinary incontinence rat model to test if it can improve the urinary incontinence and urinary urgency simultaneously.
INTRODUCTION AND OBJECTIVES: Clinically, mid-urethral sling procedure has become a regular and popular treatment for stress urinary incontinence (SUI). However, it has limited improvement if intrinsic sphincter deficiency dominantly and/or co-existing serious urgency symptom. We applied a new neuro-modulative sling in an acute urinary incontinence rat model to test if it can improve the urinary incontinence and urinary urgency simultaneously.
METHODS: The neuro-modulative sling made by sling mesh along with small silver wire electrodes which were connected to electrical stimulator with the free ends in the middle of sling for electrical stimulation. An acute mixed urinary incontinence animal model was made by bilaterally pudendual nerve transaction (PNT, n¼21) or sham PNT (n¼20) followed by potassium chloride (4M, KCl) or saline (control, 0.9% NaCl) bladder perfusion. Urodynamic testing performed to confirm the changing of the bladder contractions. Leak point pressure (LPP) was also tested during filling cytometry.
RESULTS: With current above 10mA and frequency above 50Hz result in significantly increased LPP during electrical stimulation delivering to the neuro-modulative sling (p<0.05). The continuous electrical stimulation with bi-polar square wave at the parameters of frequency to 5 Hz and pulse duration to 150 ms may decrease the increased bladder contractions significantly after PNT and KCl perfusion (p<0.01).
CONCLUSIONS: The study demonstrated the neuro-modulative sling with different electrical stimulation parameters may improve mixed urinary incontinence in an acute animal model. Our future direction is studying its effects on a long-term animal model and possible complications if long-term implantation and use. Changes in these communities are associated with benign lower urinary tract conditions, such as overactive bladder (OAB) and interstitial cystitis/painful bladder syndrome (IC/PBS). As there is significant symptomatic overlap between these two conditions, we sought to characterize changes in the urinary microbiome in a spectrum of patients with these bladder hypersensitivity syndromes to clarify potential shared pathophysiologic mechanisms.
Source of
METHODS: We used high-throughput 16S rRNA gene sequencing using an Illumina MiSeq next generation sequencing platform to identify bacterial DNA isolated from catheterized urine specimens obtained from asymptomatic controls (n¼14) and subjects with IC/PBS (n¼13) or OAB (n¼17). After classifying bacterial taxa via alignment to multiple bacterial 16S sequence databases, urinary communities were compared at a population level between experimental groups.
RESULTS: Women with OAB or IC/PBS demonstrated decreased bacterial diversity at the genus level in comparison to controls, but this difference was more profound in IC/PBS (Figure) . Several unique genera were altered in these conditions in comparison to controls. Changes in the levels of Burkholderia, a genus recently identified in association with chronic pelvic pain in males (Nickel et al., 2015) , were associated with disease in our population, with a stronger association with OAB than IC/PBS. In addition, alterations in Lactobacillus species were also prevalent in both conditions, but more pronounced in patients with IC/PBS. CONCLUSIONS: Bacterial communities resident within the lower urinary tract are altered in the presence of lower urinary tract symptoms. The microbiomes of urine from patients with OAB and IC/ PBS, however, were similar when analyzed in parallel, varying more with symptom severity than with diagnosis. Regardless of diagnosis, greater symptom severity inversely correlated with bacterial diversity. These results support recent propositions that OAB and IC/PBS may represent points on a spectrum of disease sharing a similar pathophysiology. MicroRNAs (miRNAs) may cause molecular changes in the bladder wall. Previously, using next generation sequencing (NGS) of mRNAs and miRNAs in human patients 0 biopsies we identified TNF-a as the top upstream regulator of signaling, potentially contributing to organ remodeling. Here we validated the NGS and pathway analysis in cellbased models using bladder smooth muscle (SM) and urothelial (UE) cells exposed to TNF-a.
METHODS: TNF-a-responsive genes were selected based on LUTD patients 0 NGS data and in silico analysis. SMC and UE cells were treated with 10 ng/ml TNF-a and RNA isolated. Regulation of TNF-ainduced genes was studied by qRT-PCR and comprehensive e1104 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Monday, May 15, 2017 transcriptome analysis performed by NGS. NanoString nCounter miRNA assays were used to profile miRNAs, and results validated by qRT-PCR. Cell proliferation assay was performed to evaluate the proliferative effects of TNF-a. RESULTS: Primary SM and UE cells express TNF-a receptors TNFR1 and TNFR2 and respond to TNF-a treatment. NF K B2, RelB and TNFAIP3 showed a progressive time-and concentration-dependent upregulation, and responses were stronger in SM cells compared to UE. TNF-a treatment increased cell proliferation. MiRNA expression profiling identified 17 miRNAs altered in both SMC and UE cells. MiRNAs miR-146a-5p, -21-5p, -1260a, -183-5p, -22-3p, -199a-3p, -199b-3p were similarly regulated in patients and cell-based models. MiR-26b was significantly induced in UE and SMC, but down-regulated in BOO. There was a cell-type dependent difference in miRNA profiles, with SMC-specific miRNAs gown-regulated after TNF-a treatment, in accordance with the down-regulation of SM markers and loss of contractility in human patients. Transcriptome analysis of TNF-treated cells was carried out and expression levels of predicted targets of disease-relevant miRNAs identified.
CONCLUSIONS: Our results confirm an important role of TNF-a in the regulation of BOO-specific miRNAs, and identify miRNAs linking TNF-a signaling and fibrosis. Modulation of expression levels of TNF-a-regulated miRNAs in cell-based models of human bladder using miRNA-overexpression and inhibition will elucidate their role in organ remodeling and lead to novel therapeutic approaches for BOO-induced LUTD.
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MP82-20 ATP RELATED TO VNUT MAINTAINS THE NORMAL BLADDER STORAGE FUNCTION
Hiroshi Nakagomi*, Tatsuya Miyamoto, Tatsuya Ihara, Satoru Kira, Norifumi Sawada, Takahiko Mitsui, Schuichi Koizumi, Masayuki Takeda, Chuo, Japan INTRODUCTION AND OBJECTIVES: ATP is an important substance in bladder function. Vesicular Nucleotide Transporter (VNUT) involved in exocytosis of ATP strongly expressed in the bladder urothelium. VNUT Knock out (KO) mice show frequent urination without a change in voiding function. One of the causes is the reduction of bladder compliance which based on the difficulty of the bladder urothelium surface area expansion. However all mechanism is unclear, here we underwent organ bath studies.
METHODS: All experiments were performed by using 8-14 week old male C57BL/6 mice (WT) and VNUTKO mice backcrossed (for eight generations) on a C57BL/6 background. Bladder strips (with or without urothelium) were subjected to a resting tension of 1 g and allowed to stabilize for at least 30 min. Contractions were recorded as changes in tension from baseline in response to 60 mM KCl, carbachol, and electrical field stimulation (EFS). All tissue responses were normalized to gram tissue weight.
RESULTS: The bladder without urothelium from VNUTKO mice showed a higher contractile response to 60 mM KCl compared with WT, but no change between bladders with urothelium. There was no difference in contractions by carbachol between WT and VNUTKO bladders with the presence of urothelium (Fig1). In the absence of urothelium, the responses to carbachol (Fig1) and EFS were higher in VNUTKO mice than WT mice.
CONCLUSIONS: The contraction of bladder smooth muscle in VNUTKO mice was strongly enhanced that may show the pathological state. Exocytotic ATP released from urothelium could maintain the normal bladder storage function. INTRODUCTION AND OBJECTIVES: Prostate cancer is marked by clinical and pathological heterogeneity. Therefore, there is a critical need to identify biomarkers that predict clinical presentation and outcomes. While much attention has been given to the nuclear genome, less emphasis has been placed on the maternally inherited, circular mitochondrial genome. Alterations in mitochondrial DNA (mtDNA) copy number are common in many human cancers, distinguishing cancer from normal tissue. In contrast, preliminary studies in prostate cancer, have shown no relative difference in mtDNA copy number between matched tumor-normal prostate cells, suggesting a possible field effect. The aim of this study was to test if there is a difference in mtDNA copy number between prostate cancer patients, that could be used to differentiate disease stage and clinical outcome.
Source of Funding: none
METHODS: Fresh prostate cancer biopsies from 115 patients, with a median of 107 months clinical follow-up, were H&E stained and reviewed by pathologists for tumor grade and cellularity and marked for tumor excision. DNA was extracted from tumors and qPCR performed to establish relative mtDNA abundance. Multifocal biopsies were available and examined for seven of the patients.
RESULTS: Multivariate linear models revealed a significant correlation of decreasing mtDNA copy number with estimated sample tumor cellularity (p ¼ 0.049*) and increasing with tumor pathology ISUP score (p ¼ 0.007**), but no correlation with disease relapse (p ¼ 0.60) or age (p ¼ 0.71). Data from single patient multifocal biopsies showed a similar mtDNA content (average of 1.68-fold difference, range 1.01-2.48), compared to between patient mtDNA content (upper and lower interquartile range 3.23-fold difference, total range 15.99-fold variation) CONCLUSIONS: We report a positive correlation between mtDNA count and tumor pathology score. Lack of variation in mtDNA abundance between molecular lesions within the same patients adds to
